Table 2.xls (9.5 kB)
Outcomes in costs (US$ 2012) and DALYs averted for a cohort of 10,000 individuals.
dataset
posted on 2016-06-27, 19:25 authored by Nicole T. A. Rosendaal, Marleen E. Hendriks, Mark D. Verhagen, Oladimeji A. Bolarinwa, Emmanuel O. Sanya, Philip M. Kolo, Peju Adenusi, Kayode Agbede, Diederik van Eck, Siok Swan Tan, Tanimola M. Akande, William Redekop, Constance Schultsz, Gabriela B. GomezOutcomes in costs (US$ 2012) and DALYs averted for a cohort of 10,000 individuals.
History
Usage metrics
Keywords
hypertension carefinance CVD prevention careKwara State Health Insurancesensitivityantihypertensive treatmentHealth Insurance Program Background High blood pressureSSAhealth insurance programstrategy10- year CVD riskConclusions Hypertension careKSHI programdisability-adjusted life yearpopulation-level hypertension screeningDALYcost-effectivenesshypertension grade 1grade 2 hypertensionmodel
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC